多囊卵巢综合征诊断标准不同与妊娠结局差异:79项研究的系统评价与Meta分析
该系统评价与Meta分析纳入79项研究,比较不同多囊卵巢综合征(PCOS)诊断标准下孕妇妊娠期糖尿病和子痫前期的发生情况。妊娠期糖尿病总体合并患病率为14%(95%CI 11%-18%;I²=97%),不同诊断标准间无差异;子痫前期总体合并患病率为5%(95%CI 4%-7%;I²=82%),采用美国国立卫生研究院(NIH)标准诊断的PCOS孕妇子痫前期风险较高。
要点
- PCOS孕妇妊娠期糖尿病总体合并患病率为14%(95%CI 11%-18%;I²=97%)。
- PCOS孕妇子痫前期总体合并患病率为5%(95%CI 4%-7%;I²=82%)。
- 按NIH标准诊断PCOS的孕妇子痫前期患病率最高,为14%(95%CI 5%-33%;I²=90%)。
核心结论
- PCOS孕妇妊娠期糖尿病的患病率不随所用诊断标准而变化,但按NIH标准诊断PCOS的孕妇子痫前期风险较高。
研究设计与样本
- 系统评价与Meta分析,共纳入79项研究。
- 研究对象为患有PCOS的孕妇。
- 比较不同PCOS诊断标准下孕妇及新生儿并发症的发生情况。
主要发现
- 妊娠期糖尿病总体合并患病率为14%(95%CI 11%-18%;I²=97%)。
- 采用超声多囊卵巢形态加其余2项鹿特丹标准中1项(1/2鹿特丹标准)时妊娠期糖尿病患病率最高,为18%(95%CI 13%-24%;I²=20%)。
- 采用超声多囊卵巢形态加高雄激素血症时妊娠期糖尿病患病率最低,为3%(95%CI 0%-19%;I²不适用)。
- 子痫前期总体合并患病率为5%(95%CI 4%-7%;I²=82%)。
- 采用NIH标准时子痫前期患病率最高,为14%(95%CI 5%-33%;I²=90%);采用月经不规则加2项鹿特丹标准中1项时最低,为2%(95%CI 1%-3%;I²不适用)。
临床怎么用
- 作者认为,PCOS孕妇妊娠期糖尿病患病率不因诊断标准不同而异,但按NIH标准诊断PCOS的孕妇子痫前期风险较高。
局限性
- 妊娠期糖尿病总体合并患病率的异质性I²=97%。
- 子痫前期总体合并患病率的异质性I²=82%。
- 采用NIH标准时子痫前期患病率的异质性I²=90%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To correlate the distinct diagnostic criteria of polycystic ovary syndrome (PCOS) with the development of maternal and neonatal complications. DESIGN: Systematic review and meta-analysis. SETTING: Not applicable. PATIENT(S): Pregnant women with PCOS. INTERVENTION(S): Maternal and neonatal complications were compared among women with PCOS diagnosed with different criteria. MAIN OUTCOME MEASURE(S): The primary outcomes of gestational diabetes mellitus and preeclampsia (PE) were assessed for every diagnostic criterion. RESULT(S): Seventy-nine studies were included. Regarding gestational diabetes, the overall pooled prevalence was 14% (95% confidence interval [CI], 11%-18%; I2, 97%), reaching the highest level when polycystic ovarian morphology on ultrasound and 1 of the remaining 2 Rotterdam criteria (1/2 Rotterdam criteria) were used (18%; 95% CI, 13%-24%; I2, 20%) and the lowest when polycystic morphology on ultrasound and hyperandrogenism were used (3%; 95% CI, 0%-19%; I2, not applicable). Regarding PE, the overall pooled prevalence was 5% (95% CI, 4%-7%; I2, 82%). The highest PE prevalence was reported when the National Institutes of Health criteria were used (14%; 95% CI, 5%-33%; I2, 90%) and the lowest when menstrual irregularities and 1 of the 2 Rotterdam criteria were used (2%; 95% CI, 1%-3%; I2, not applicable). CONCLUSION(S): The prevalence of gestational diabetes mellitus in pregnant women with PCOS does not differ according to the criteria used; however, women diagnosed with PCOS per the National Institutes of Health criteria are at higher risk of PE.
引用
- Chatzakis C, Tsakmaki E, Psomiadou A, et al. Different pregnancy outcomes according to the polycystic ovary syndrome diagnostic criteria: a systematic review and meta-analysis of 79 studies. Fertil Steril. 2022. PMID: 35120743. doi:10.1016/j.fertnstert.2021.12.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。